Study Summary
This trial will test whether adding the Regeneten implant to repair the subscapularis tendon after anatomic total shoulder arthroplasty can improve healing rates and clinical outcomes.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 9 Secondary · Reporting Duration: 12 months
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Regeneten
1 of 1
Active Control
50 Total Participants · 1 Treatment Group
Primary Treatment: Regeneten · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
To what capacity is recruitment for this research endeavor occurring?
"Affirmative. The data hosted on clinicaltrials.gov show that this medical experiment, first posted July 14th 2020, is currently seeking participants. Fifty patients need to be enrolled at one specific site." - Anonymous Online Contributor
Are new participants welcome to join the research study at this juncture?
"As per clinicaltrials.gov, this trial is still recruiting participants with the initial posting on July 14th 2020 and most recently updated April 22nd 2021." - Anonymous Online Contributor